|
|
Post by cjm18 on Feb 6, 2024 9:10:22 GMT -5
|
|
|
|
Post by mango on Feb 6, 2024 9:44:15 GMT -5
It’s fascinating how some people will still spin insider buying into something negative. These type of people are just complainers and can never be happy or satisfied. The fact they remain invested in an asset they detest is equally as fascinating! Did you ever consider maybe they don’t detest the “asset” as much as how it has been managed? Or that they still believe in the right hands it could have great value? Or that they believe the price has been beaten down so low it would be the wrong time to sell? Or any and all of the above… No, I don’t consider those valid reasons to remain in an asset I detest. The same people complaining about current management complained about prior management. They are just complainers. I suspect they cling to their hatred so stubbornly because nothing helps a bad mood like spreading it around, and once it’s gone, what will they have left? |
|
|
|
Post by cretin11 on Feb 6, 2024 10:16:36 GMT -5
Well then you suspect wrong. Most of the folks you call “complainers” are not at all that way IRL. And as I just said, they probably don’t detest the “asset” so your premise is flawed. This is a message board open for commentary about a stock, namely MNKD. Take a look at MNKD share price performance the past _____ (you choose)years. One would expect a fair amount of critique directed at the decision makers for such stock performance. In fact, the critique is remarkably muted here compared to any other forum for a stock having similar track record, especially in the context of said stock involving an “asset” as remarkable as Afrezza.
|
|
|
|
Post by mango on Feb 6, 2024 11:23:14 GMT -5
Well then you suspect wrong. Most of the folks you call “complainers” are not at all that way IRL. And as I just said, they probably don’t detest the “asset” so your premise is flawed. This is a message board open for commentary about a stock, namely MNKD. Take a look at MNKD share price performance the past _____ (you choose)years. One would expect a fair amount of critique directed at the decision makers for such stock performance. In fact, the critique is remarkably muted here compared to any other forum for a stock having similar track record, especially in the context of said stock involving an “asset” as remarkable as Afrezza. You can claim I suspect wrong all you want, but it won’t make you right! I see complainers (including you) on here and Stocktwits everyday. There is even so called “Longs” who espouse all the time how “Afrezza is dead” yet remain invested. |
|
|
|
Post by cretin11 on Feb 6, 2024 11:53:12 GMT -5
Some of the posters on ST are ridiculous, that goes for pumpers and bashers. I don't even give them any credence whatsoever. There are some posters there who use logic and facts to support their opinions, and again those are on both sides of the optimistic/pessimistic fence. The ones on the pessimistic side tend to fit the description I've given, whether you care to acknowledge that is your choice. Some of them wonder, how long is a typical CEO tenure? I see different reports, for example 39% of S&P 500 (i know we aren't in that group) CEOs have tenures ranging from one to five years, and another 28% are between five and ten years. So for a loyal and stubborn MNKD long who believes new leadership could help us finally realize Afrezza's and TechnoSphere's potential, those statistics give some hope and a reason to stick it out a while longer.
Of course, the real long suffering shareholders said the same thing about the last leadership we had. Change doesn't always mean improvement, and one must consider who are the people making such transition decisions. That realization doesn't give one the warm and fuzzies when it comes to MNKD. It's a recipe for a zombie stock so here we sit, playing the slow game and hoping for some long overdue good news.
And I'm not one who has ever said "Afrezza is dead" but if not for Bill and VDEX I'd have to consider that possibility. Would be blind not to consider it.
|
|
|
|
Post by mango on Feb 6, 2024 12:27:48 GMT -5
Some of the posters on ST are ridiculous, that goes for pumpers and bashers. I don't even give them any credence whatsoever. There are some posters there who use logic and facts to support their opinions, and again those are on both sides of the optimistic/pessimistic fence. The ones on the pessimistic side tend to fit the description I've given, whether you care to acknowledge that is your choice. Some of them wonder, how long is a typical CEO tenure? I see different reports, for example 39% of S&P 500 (i know we aren't in that group) CEOs have tenures ranging from one to five years, and another 28% are between five and ten years. So for a loyal and stubborn MNKD long who believes new leadership could help us finally realize Afrezza's and TechnoSphere's potential, those statistics give some hope and a reason to stick it out a while longer. Of course, the real long suffering shareholders said the same thing about the last leadership we had. Change doesn't always mean improvement, and one must consider who are the people making such transition decisions. That realization doesn't give one the warm and fuzzies when it comes to MNKD. It's a recipe for a zombie stock so here we sit, playing the slow game and hoping for some long overdue good news. And I'm not one who has ever said "Afrezza is dead" but if not for Bill and VDEX I'd have to consider that possibility. Would be blind not to consider it. I believe Mike has a pulse on every aspect of the business and has the business’s best interests in mind. Having said that, he has made some poor choices (Damon Dash, NRx Pharma, Immix or whatever they are called, and possibly VGo but it’s too soon to say because the additional asset in the bag gives reps more access to Endos especially for the upcoming Peds approval). Perhaps the BODs and Mike have a long term plan they believe is achievable with Mike before he moves on? There’s a lot happening with the Company right now, multiple clinical trials and an evolving pipeline, recent approval of Tyvaso DPI, etc. Mike wants either a new drug approved, new pipeline asset or new indications added to existing assets starting 2025-2030. We’re on track to see that. Perhaps that is why there hasn’t been a change in leadership, IMO. The share price sucks no doubt I’m pretty happy with all the developments taking place and where the Company is at financially right now. Some have run out of patience with the PPS which is understandable. |
|
|
|
Post by standup on Feb 6, 2024 13:35:41 GMT -5
Some of the posters on ST are ridiculous, that goes for pumpers and bashers. I don't even give them any credence whatsoever. There are some posters there who use logic and facts to support their opinions, and again those are on both sides of the optimistic/pessimistic fence. The ones on the pessimistic side tend to fit the description I've given, whether you care to acknowledge that is your choice. Some of them wonder, how long is a typical CEO tenure? I see different reports, for example 39% of S&P 500 (i know we aren't in that group) CEOs have tenures ranging from one to five years, and another 28% are between five and ten years. So for a loyal and stubborn MNKD long who believes new leadership could help us finally realize Afrezza's and TechnoSphere's potential, those statistics give some hope and a reason to stick it out a while longer. Of course, the real long suffering shareholders said the same thing about the last leadership we had. Change doesn't always mean improvement, and one must consider who are the people making such transition decisions. That realization doesn't give one the warm and fuzzies when it comes to MNKD. It's a recipe for a zombie stock so here we sit, playing the slow game and hoping for some long overdue good news. And I'm not one who has ever said "Afrezza is dead" but if not for Bill and VDEX I'd have to consider that possibility. Would be blind not to consider it. I believe Mike has a pulse on every aspect of the business and has the business’s best interests in mind. Having said that, he has made some poor choices (Damon Dash, NRx Pharma, Immix or whatever they are called, and possibly VGo but it’s too soon to say because the additional asset in the bag gives reps more access to Endos especially for the upcoming Peds approval). Perhaps the BODs and Mike have a long term plan they believe is achievable with Mike before he moves on? There’s a lot happening with the Company right now, multiple clinical trials and an evolving pipeline, recent approval of Tyvaso DPI, etc. Mike wants either a new drug approved, new pipeline asset or new indications added to existing assets starting 2025-2030. We’re on track to see that. Perhaps that is why there hasn’t been a change in leadership, IMO. The share price sucks no doubt I’m pretty happy with all the developments taking place and where the Company is at financially right now. Some have run out of patience with the PPS which is understandable. Even a blind squirrel finds a nut now and then. |
|
|
|
Post by cretin11 on Feb 6, 2024 14:04:38 GMT -5
Let’s hope so!
|
|
|
|
Post by ktim on Feb 6, 2024 15:08:22 GMT -5
Well then you suspect wrong. Most of the folks you call “complainers” are not at all that way IRL. And as I just said, they probably don’t detest the “asset” so your premise is flawed. This is a message board open for commentary about a stock, namely MNKD. Take a look at MNKD share price performance the past _____ (you choose)years. One would expect a fair amount of critique directed at the decision makers for such stock performance. In fact, the critique is remarkably muted here compared to any other forum for a stock having similar track record, especially in the context of said stock involving an “asset” as remarkable as Afrezza. You can claim I suspect wrong all you want, but it won’t make you right! I see complainers (including you) on here and Stocktwits everyday. There is even so called “Longs” who espouse all the time how “Afrezza is dead” yet remain invested. No one here is now saying Afrezza is dead.... at least not that I've seen. I take management's Afrezza projection at face value. Afrezza isn't going to be a blockbuster, but will turn moderately profitable. The growth is primarily in Tyvaso and the pipeline. I remain invested (and in fact been buying more recently) despite having lackluster expectations for Afrezza. |
|
|
|
Post by akemp3000 on Feb 6, 2024 16:05:13 GMT -5
Frustration with the pps is understandable but Afrezza is clearly alive with the head-to-head study results and pediatric approval likely forthcoming.
|
|
|
|
Post by Clement on Feb 6, 2024 16:28:53 GMT -5
Frustration with the pps is understandable but Afrezza is clearly alive with the head-to-head study results and pediatric approval likely forthcoming. I like this post but "forthcoming" in this case means about two years. "Estimated Study Completion Date : April 2025" classic.clinicaltrials.gov/ct2/show/NCT04974528Add 6 to 9 months to that. |
|
|
|
Post by hellodolly on Feb 6, 2024 16:29:44 GMT -5
It’s fascinating how some people will still spin insider buying into something negative. These type of people are just complainers and can never be happy or satisfied. The fact they remain invested in an asset they detest is equally as fascinating! Did you ever consider maybe they don’t detest the “asset” as much as how it has been managed? Or that they still believe in the right hands it could have great value? Or that they believe the price has been beaten down so low it would be the wrong time to sell? Or any and all of the above… You make great points. What I don't appreciate is leaving out the rest of the story. A lot of the reasons' for selling that were listed in the footnotes and they include just some of the following: 12/14/2023 200,482 sharesTransaction occurred pursuant to Rule 10B5-1 Plan established December 19, 2022. All transactions contemplated by such plan have now been completed. Transaction occurred pursuant to Rule 10B5-1 Plan established September 1, 2023. Transaction occurred pursuant to Rule 10B5-1 Plan established September 1, 2023. All transactions contemplated by such plan have now been completed. 11/1/2023 10,000 sharesTransaction occurred pursuant to Rule 10B5-1 Plan established December 19, 2022 10/02/2023 10,000 sharesShares withheld to satisfy the tax liability incident to the vesting of previously reported restricted stock units. 9/1/2023 76,892 sharesTransaction occurred pursuant to Rule 10B5-1 Plan established December 19, 2022. Reporting person transferred 66,892 shares of MNKD common stock to his ex-spouse pursuant to a divorce decree on September 5, 2023. 8/27/2023 50,696 sharesShares withheld to satisfy the tax liability incident to the vesting of previously reported restricted stock units. 8/1/2023 10,000 sharesTransaction occurred pursuant to Rule 10B5-1 Plan established December 19, 2022. 7/5/2023 10,000 sharesTransaction occurred pursuant to Rule 10B5-1 Plan established December 19, 2022. 6/2/2023 10,000 sharesTransaction occurred pursuant to Rule 10B5-1 Plan established December 19, 2022. 5/25/2023 150,000 sharesTransaction occurred pursuant to a Rule 10B5-1 Plan adopted on December 5, 2022. We all see the transactions for what they are. For those who do not know Rule 10B5-1 Rule 10b5-1 stops any insiders from changing or adopting a plan if they are in possession of material nonpublic information (MNPI). It is not uncommon to see a major shareholder sell some of their shares at regular intervals. A director of XYZ Corporation, for example, may choose to sell 5,000 shares of stock on the second Wednesday of every month. To avoid conflict, Rule 10b5-1 plans must be established when the individual is unaware of any MNPI. These plans usually exist as a contract between the insider and their broker. Under Rule 10b5-1, directors and other major insiders in the company—large shareholders, officers, and others who have access to MNPI—can establish a written plan that details when they can buy or sell shares at a predetermined time on a scheduled basis. It is set up this way so that they are able to make these transactions when they are not in the vicinity of MNPI. This also allows companies to utilize 10b5-1 plans in large stock buybacks. Source: Investopedia www.investopedia.com/terms/r/rule-10b5-1.aspThe crawl here with those who post objectionable replies to the original thread, is their ability and wherewithal to tell the entire narrative is not in their best interest. Why? I have no problem jumping in and criticizing, as I did about the failure of insiders to buy at such bargain basement prices. Mike says the company is undervalued, so let's see them buy. Now that we see several transactions, surely established with their legal counsel to coordinate them without casting any doubt as to whether they are acting on MNPI, their thesis changes or, they are two genes short of a chromosome and think the members here can't see the obvious. What is obvious, to make accusations that are unfounded. I just dug up a half years worth of Mike's Form 4s to research why the trades were made. "Did you ever consider maybe they don’t detest the “asset” as much as how it has been managed? Or that they still believe in the right hands it could have great value? Or that they believe the price has been beaten down so low it would be the wrong time to sell? Or any and all of the above…" Let me ask, do you believe the insider transactions have caused the drop in SP or, do you think, after MC brought this company back from the brink of near bankruptcy with only enough cash for 1 quarter and the SP hitting low sub $1 he's suddenly lost his fiduciary obligations because he pre-planned his sells, filed the regulatory documents with the SEC in order to exercise his options as the owner to dispose of his earned MNKD shares? Does he lose that right as a CEO or, do we just default to the old "it's the optics of it" that are the problem? |
|
|
|
Post by agedhippie on Feb 6, 2024 17:09:25 GMT -5
"Did you ever consider maybe they don’t detest the “asset” as much as how it has been managed? Or that they still believe in the right hands it could have great value? Or that they believe the price has been beaten down so low it would be the wrong time to sell? Or any and all of the above…" Let me ask, do you believe the insider transactions have caused the drop in SP or, do you think, after MC brought this company back from the brink of near bankruptcy with only enough cash for 1 quarter and the SP hitting low sub $1 he's suddenly lost his fiduciary obligations because he pre-planned his sells, filed the regulatory documents with the SEC in order to exercise his options as the owner to dispose of his earned MNKD shares? Does he lose that right as a CEO or, do we just default to the old "it's the optics of it" that are the problem? Optics are not even a problem. In my experience there is zero expectation amongst the big traders that any CEO will never sell shares. There is also relatively little expectation that they will buy them either beyond those they can get cheaply. If the CEO does buy then it's viewed as the CEO trying to prop up the share price. MNKD's chart is a more volatile version of UTHR's chart - this is nothing to do with the CEO for once. |
|
|
|
Post by cretin11 on Feb 6, 2024 17:30:24 GMT -5
Agree with aged. Thanks for the long winded defense of all his small and enormous share sales, but I couldn’t care less whether mc buys or sells shares, when he buys/sells, etc. … IF he were performing at a high level and creating shareholder value. I’ve consistently said that for a long time. You apparently think he’s meeting that hurdle and you’re entitled to your opinion. Others aren’t required to share it, some do share it and some do not. And he’s not the first MNKD ceo to not live up to expectations, I just hope whoever is next can break the mold. I’d also be delighted if mc himself could reverse his performance and I’m open to it but realistic about those odds.
|
|
|
|
Post by hellodolly on Feb 6, 2024 19:01:40 GMT -5
Agree with aged. Thanks for the long winded defense of all his small and enormous share sales, but I couldn’t care less whether mc buys or sells shares, when he buys/sells, etc. … IF he were performing at a high level and creating shareholder value. I’ve consistently said that for a long time. You apparently think he’s meeting that hurdle and you’re entitled to your opinion. Others aren’t required to share it, some do share it and some do not. And he’s not the first MNKD ceo to not live up to expectations, I just hope whoever is next can break the mold. I’d also be delighted if mc himself could reverse his performance and I’m open to it but realistic about those odds. Long winded defense? If left unanswered, without the facts, I'd be ignoring my investment's short term & long term goals. I care a lot about where I invest and there are some very valued members here that I respect that keep the discussion on point. Then, we have windbags who post the same mindless drivel that need constant reminders that the space between their ears is called cranial cavity and inside is a brain. I dialed into his share transactions, as that seems to be a sticking point with some of the cranial voids infesting the board. Everything else mentioned "expectations, performance, value" being equal, they're important as well, just not the focus of my reply. The reply was a spirited look back at the "actual sales" and not some random and arbitrary hit about his ownership of the shares. My bet is if you ask Mike if he'd rather sell his shares at 4X, 8X 10X his cost basis or vestment basis, even a genius like those with voids between their ears would be able to tell you what Mike would say. It's not like he's sitting around in his office thinking of how he can best destroy value. He's a very smart and intelligent CEO that has arranged his priorities based on what is urgent and important back down to not-urgent and not-important. He doesn't do this in a vacuum, every step is measured. He's made it clear that he steps ahead, in years. Ihope that sheds some light on my focus...my investment is my focus. |
|
